SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-107609
Filing Date
2021-04-06
Accepted
2021-04-06 16:21:31
Documents
4
Effectiveness Date
2021-04-06

Document Format Files

Seq Description Document Type Size
1 S-8 d26608ds8.htm S-8 66330
2 EX-5.1 d26608dex51.htm EX-5.1 49969
3 EX-23.1 d26608dex231.htm EX-23.1 1869
4 GRAPHIC g26608g0406202542041.jpg GRAPHIC 3093
  Complete submission text file 0001193125-21-107609.txt   123767
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX 44 (0) 1438 906855
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255063 | Film No.: 21809404
SIC: 2836 Biological Products, (No Diagnostic Substances)